Current strategies for the prevention of postpartum haemorrhage in the third stage of labour

Current Opinion in Obstetrics and Gynecology

Volumn 16, Issue 2, 2004, Pages 143-150

  Chong, Yap Seng ^a   Su, Lin Lin ^a   Arulkumaran, Sabaratnam ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Active management; Carbetocin; Expectant management; Misoprostol; Oxytocics

Indexed keywords

CARBETOCIN; CARBOPROST; CARBOPROST METHYL; CARBOPROST TROMETAMOL; ERGOMETRINE MALEATE; ERGOMETRINE PLUS OXYTOCIN; ERGOT ALKALOID; METHYLERGOMETRINE; MISOPROSTOL; OXYTOCIC AGENT; OXYTOCIN; PROSTAGLANDIN; UTEROTONIC AGENT;

ABDOMINAL CRAMP; BLEEDING; CHILDBIRTH; CLINICAL TRIAL; DIARRHEA; HUMAN; HYPERTENSION; LABOR; NAUSEA; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; PUBLICATION; REVIEW; VOMITING;

DELIVERY, OBSTETRIC; ERGONOVINE; FEMALE; HUMANS; LABOR STAGE, THIRD; MISOPROSTOL; OXYTOCICS; OXYTOCIN; POSTPARTUM HEMORRHAGE; PREGNANCY; PROSTAGLANDINS; RANDOMIZED CONTROLLED TRIALS;

EID: 1942454465     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-200404000-00008     Document Type: Review

References (80)

1. Li XF, Fortney JA, Kotelchuck M, Glover LH. The postpartum period: the key to maternal mortality. Int J Gynecol Obstet 1996; 54:1-10.
2. Tsu VD. Postpartum haemorrhage in Zimbabwe: a risk factor analysis. Br J Obstet Gynaecol 1993; 100:327-333.
3. Kane TT, El-Kady AA, Saleh S, et al. Maternal mortality in Giza, Egypt: magnitude, causes, and prevention. Stud Fam Plann 1992; 23:45-57.
4. Moir JC. The history of present day use of ergot. Can Med Assoc J 1955; 72:727-734.
5. Prendiville W, Elbourne D, Chalmers I. The effects of routine oxytocic administration in the management of the third stage of labour: an overview of the evidence from controlled trials. Br J Obstet Gynaecol 1988; 95:3-16.
6. Festin MR, Lumbiganon P, Tolosa JE, et al. International survey on variations in practice of the management of the third stage of labour. Bull World Health Organ 2003; 81:286-291. Epub 16 May 2003. http://www.scielosp.org/ scielo.php?script=sci_arttext&pid=S0042-96862003000400010&lng= en&nrm=iso&tlng=es An excellent article which addresses the issue of evidence-based medicine for the management of the third stage of labour. The variations in practices and the areas for improvement are identified.
7. De Groot AN, van Roosmalen J, van Dongen PW. Survey of the management of third stage of labour in The Netherlands. Eur J Obstet Gynecol Reprod Biol 1996; 66:39-40.
8. Bjornerem A, Acharya G, Oian P, Maltau JM. Postpartum hemorrhage: prophylaxis and treatment in Norway. Tidsskr Nor Laegeforen 2002; 122:2536-2537. This survey reveals the low implementation rate of routine prophylaxis for the third stage of labour in Norway.
9. Brucker MC. Management of the third stage of labor: an evidence-based approach. J Midwifery Womens Health 2001; 46:381-392.
10. Phillips CA, Kinch RA. Management of the third stage of labor: a survey of practice among Texas obstetricians. Tex Med 1994; 90:44-47.
11. O'Brien WF, Cefalo RC. Labour and delivery. In: Gabbe SG, Niebyl JR, Simpson JL, editors. Obstetrics: normal and problem pregnancies. 3rd ed. New York: Churchill Livingstone; 1996. p. 388.
12. Jackson KW Jr, Allbert JR, Schemmer GK, et al. A randomized controlled trial comparing oxytocin administration before and after placental delivery in the prevention of postpartum hemorrhage. Am J Obstet Gynecol 2001; 185:873-877.
13. Harding JE, Elbourne DR, Prendiville WJ. Views of mothers and midwives participating in the Bristol randomized, controlled trial of active management of the third stage of labor. Birth 1989; 16:1-6.
14. Garcia J, Garforth S. Labour and delivery routines in English consultant maternity units. Midwifery 1989; 5:155-162.
15. McCormick ML, Sanghi HCG, Kinzie B, McIntosh N. Preventing postpartum hemorrhage in low-resource settings. Int J Gynecol Obstet 2002; 77:267-275. A systematic review to determine the most effective method for prevention of postpartum haemorrhage in low-resource settings.
16. Prendiville WJ, Harding JE, Elbourne DR, Stirrat GM. The Bristol third stage trial: active vs physiological management of the third stage of labour. BMJ 1988; 297:1295-1300.
17. Begley CM. A comparison of 'active' and 'physiological' management of the third stage of labour. Midwifery 1990; 6:3-17.
18. Thilaganathan B, Cutner A, Latimer J, Beard R. Management of the third stage of labour in women at low risk of postpartum haemorrhage. Eur J Obstet Gynecol Reprod Biol 1993; 48:19-22.
19. Khan GQ, John LS, Wani S, et al. Controlled cord traction versus minimal intervention techniques in delivery of the placenta: a randomized controlled trial. Am J Obstet Gynecol 1997; 77:770-774.
20. Rogers J, Wood J, McCandlish R, et al. Active vs expectant management of the third stage of labour: the Hinchingbrooke randomised controlled trial. Lancet 1998; 351:693-699.
21. Prendiville WJ, Elbourne D, McDonald S. Active versus expectant management in the third stage of labour [Cochrane review]. The Cochrane Library 2003; (3). Oxford: Update Software. A comprehensive systematic review which clearly shows the various benefits of active management in the third stage of labour.
22. McDonald S, Prendiville WJ, Elbourne D. Prophylactic syntometrine versus oxytocin for delivery of the placenta [Cochrane review]. The Cochrane Library 2003; (3). Oxford: Update Software. A Cochrane review that assesses the efficacy of syntometrine and oxytocin for the third stage of labour. The efficacy and adverse effect profile of the medications are discussed.
23. Nieminen U, Jarvinen PA. A comparative study of different medical treatments of the third stage of labour. Ann Chir Gynaecol Fenn 1963; 53:424-429.
24. Dumoulin JG. A reappraisal of the use of ergometrine. J Obstet Gynaecol 1981; 1:178-181.
25. McDonald SJ, Prendiville W, Blair E. Randomised controlled trial of oxytocin alone versus oxytocin and ergometrine in active management of the third stage of labour. BMJ 1993; 307:1167-1171.
26. Mitchell GG, Elbourne DR. The Salford third stage trial: oxytocin plus ergometrine versus oxytocin alone in the active management of the third stage of labour. Online J Curr Clin Trials 1993; 2:Doc 83.
27. Khan GQ, John IS, Chan T, et al. Abu Dhabi third stage trial: oxytocin versus syntometrine in the active management of the third stage of labour. Eur J Obstet Gynaecol and Reprod Biol 1995; 58:147-151.
28. Yuen PM, Chan NST, Yim SF, Chang AMZ. A randomised double blind comparison of syntometrine and syntocinon in the management of the third stage of labour. Br J Obstet Gynaecol 1995; 102:377-380.
29. Choy CM, Lau WC, Tam WH, Yuen PM. A randomised controlled trial of intramuscular syntometrine and intravenous oxytocin in the management of the third stage of labour. BJOG 2002; 109:173-177. The authors reported the results of a randomized controlled trial which showed no significant difference in the efficacy of syntometrine and oxytocin for the prevention of postpartum haemorrhage.
30. Elbourne DR, Prendiville WJ, Carroli G, et al. Prophylactic use of oxytocin in the third stage of labour [Cochrane review]. The Cochrane Library 2003; (3). Oxford: Update Software. Confirms that prophylactic oxytocin alone is beneficial in terms of preventing postpartum haemorrhage, and the need for additional therapeutic oxytocics.
31. Newton M, Mosey LM, Egli GE, et al. Blood loss during and immediately after delivery. Obstet Gynecol 1961; 17:9-18.
32. Howard WF, McFadden PR, Keettel WC. Oxytocic drugs in fourth stage of labor. JAMA 1964; 189:411-413.
33. Ilancheran A, Ratnam SS. Effect of oxytocics on prostaglandin levels in the third stage of labour. Gynecol Obstet Invest 1990; 29:177-180.
34. Poeschmann RP, Doesburg WH, Eskes TKAB. A randomized comparison of oxytocin, sulprostone and placebo in the management of the third stage of labour. Br J Obstet Gynaecol 1991; 98:528-530.
35. Pierre F, Mesnard L, Body G. For a systematic policy of iv oxytocin inducted placenta deliveries in a unit where a fairly active management of third stage of labour is yet applied: results of a controlled trial. Eur J Obstet Gynecol Reprod Biol 1992; 43:131-135.
36. De Groot ANJA, Van Roosmalen J, Van Dongen PWJ, Borm GF. A placebo-controlled trial of oral ergometrine to reduce postpartum hemorrhage. Acta Obstet Gynecol Scand 1996; 75:464-468.
37. Nordstrom L, Fogelstam K, Fridman G, et al. Routine oxytocin in the third stage of labour: a placebo controlled randomised trial. Br J Obstet Gynaecol 1997; 104:781-786.
38. McGinty LB. A study of the vasopressor effects of oxytocics when used intravenously in the third stage of labour. West J Surg 1956; 64:22-28.
39. Fugo NW, Dieckmann WJ. A comparison of oxytocic drugs in the management of the placental stage. Am J Obstet Gynecol 1958; 76:141-146.
40. Sorbe B. Active pharmacologic management of the third stage of labor: a comparison of oxytocin and ergometrine. Obstet Gynecol 1978; 52:694-697.
41. Barbaro CA, Smith GO. Clinical trial of SE505: a new oxytocic mixture. Aust N Z J Obstet Gynaecol 1961; 1:147-150.
42. Bonham DG. Intramuscular oxytocics and cord traction in third stage of labour. BMJ 1963; 2:1620-1623.
43. Soiva K, Koistinen O. Clinical experience with simultaneous intramuscular injection of oxytocin and methylergometrine. Ann Chir Gynaecol 1964; 53:173-186.
44. Francis HH, Miller JM, Porteous CR. Clinical trial of an oxytocin-ergometrine mixture. J Obstet Gynaecol 1965; 5:47-51.
45. Chestnut DH, Wilcox LL. Influence of umbilical vein administration of oxytocin on the third stage of labor: a randomized, double-blind, placebo-controlled study. Am J Obstet Gynecol 1987; 157:160-162.
46. Young SB, Martelly PD, Greb L, et al. The effect of intraumbilical oxytocin on the third stage of labor. Obstet Gynecol 1988; 71:736-738.
47. Bider D, Zolti M, Menashe Y, et al. Oxytocin or saline injected intra-umbilically did not influence the third stage of labor. Acta Obstet Gynecol Scand 1991; 70:321-323.
48. Ozcan T, Sahin G, Senoz S. The effect of intraumbilical oxytocin on the third stage of labour. Aust N Z J Obstet Gynaecol 1996; 36:9-11.
49. Athavale RD, Nerurkar NM, Dalvi SA, Bhattacharya MS. Umbilical vein oxytocin in the management of third stage of labour. J Postgrad Med 1991; 37:219-220.
50. Kovavisarach E, Rojsangruang S. Effect of umbilical vein oxytocin injection on the third stage of labor: a randomized controlled study. J Med Assoc Thai 1998; 81:693-697.
51. Reddy VV, Carey JC. Effect of umbilical vein oxytocin on puerperal blood loss and length of the third stage of labor. Am J Obstet Gynecol 1989; 160:206-208.
52. Dahiya P, Puri M, Rathee S. Influence of intraumbilical oxytocin on the third stage of labour. Indian J Med Sci 1995; 49:23-27.
53. Porter KB, O'Brien WF, Collins MK, et al. A randomized comparison of umbilical vein and intravenous oxytocin during the puerperium. Obstet Gynecol 1991; 78:254-256.
54. Carroli G, Bergel E. Umbilical vein injection for management of retained placenta [Cochrane review]. The Cochrane Library 2003; (3). Oxford: Update Software. A Cochrane review which concludes that umbilical vein injection has a promising role for the management of retained placenta.
55. Bider D, Ben-Rafael Z, Dulitzky M, et al. Effect of intraumbilical prostaglandin F2 alpha injection on the third stage of labor. J Reprod Med 1992; 37:317-319.
56. Reichev R, Dimitrov N, Raicheva R. Provocation of labor activity by oral administration of methylergobasine (methergine) by Merger's method (R. Merger). Akush Ginekol (Sofiia) 1972; 11:388-392.
57. Andersen B, Andersen LL, Sorensen T. Methylergometrine during the early puerperium: a prospective randomized double blind study. Acta Obstet Gynecol Scand 1998; 77:54-57.
58. De Groot AN, van Dongen PW, Vree TB, et al. Ergot alkaloids: current status and review of clinical pharmacology and therapeutic use compared with other oxytocics in obstetrics and gynaecology. Drugs 1998; 56:523-535.
59. De Groot AN, Vree TB, Hekster YA, et al. Bioavailability and pharmacokinetics of sublingual oxytocin in male volunteers. J Pharm Pharmacol 1995; 47:571-575.
60. Chua S, Chew SL, Yeoh CL, et al. A randomized controlled study of prostaglandin 15-methyl F2 alpha compared with syntometrine for prophylactic use in the third stage of labour. Aust N Z J Obstet Gynaecol 1995; 35:413-416.
61. Lamont RF, Morgan DJ, Logue M, Gordon H. A prospective randomised trial to compare the efficacy and safety of hemabate and syntometrine for the prevention of primary postpartum haemorrhage. Prostaglandins Other Lipid Mediat 2001; 66:203-210.
62. Gulmezoglu AM. Prostaglandins for prevention of postpartum haemorrhage. Cochrane Database Syst Rev 2000; (2):CD000494.
63. Atke A, Vilhardt H. Uterotonic activity and myometrial receptor affinity of 1-deamino-1-carba-2-tyrosine(O-methyl)-oxytocin. Acta Endocrinol (Copenh) 1987; 115:155-160.
64. Hunter DJ, Schulz P, Wassenaar W. Effect of carbetocin, a long-acting oxytocin analog on the postpartum uterus. Clin Pharmacol Ther 1992; 52:60-67.
65. van Dongen PW, Verbruggen MM, de Groot AN, et al. Ascending dose tolerance study of intramuscular carbetocin administered after normal vaginal birth. Eur J Obstet Gynecol Reprod Biol 1998; 77:181-187.
66. Boucher M, Horbay GL, Griffin P, et al. Double-blind, randomized comparison of the effect of carbetocin and oxytocin on intraoperative blood loss and uterine tone of patients undergoing cesarean section. J Perinatol 1998; 18:202-207.
67. Dansereau J, Joshi AK, Helewa ME, et al. Double-blind comparison of carbetocin versus oxytocin in prevention of uterine atony after cesarean section. Am J Obstet Gynecol 1999; 180 (3 Pt 1):670-676.
68. Goldberg AB, Greenberg MB, Darney PD. Misoprostol and pregnancy. N Engl J Med 2001; 344:38-47.
69. El-Refaey H, O'Brien P, Morafa W, et al. Misoprostol for third stage of labour [letter]. Lancet 1996; 347:1257.
70. Bamigboye AA, Merrell DA, Hofmeyr GJ, Mitchell R. Randomized comparison of rectal misoprsotol with syntometrine for management of third stage of labor. Acta Obstet Gynecol Scand 1998; 77:178-181.
71. Gulmezoglu AM, Forna F, Villar J, Hofmeyr GJ. Prostaglandins for prevention of postpartum haemorrhage. Cochrane Database Syst Rev 2002; (3):CD000494. A Cochrane review which assesses the use of prophylactic prostaglandins in the third stage of labour. Comprehensive studies of the various randomized trials make this a useful scientific review.
72. Villar J, Gulmezoglu AM, Hofmeyr GJ, Forna F. Systematic review of randomized controlled trials of misoprostol to prevent postpartum hemorrhage. Obstet Gynecol 2002; 100:1301-1312. An excellent systematic review assessing the efficacy and side-effect profile of misoprostol for the prevention of postpartum haemorrhage.
73. Joy SD, Sanchez-Ramos L, Kaunitz AM. Misoprostol use during the third stage of labor. Int J Gynecol Obstet 2003; 82:143-152. The most recent systematic review looking at the use of misoprostol for the prevention of postpartum haemorrhage, particularly from the point of view of developing countries with scarce resources.
74. Tang OS, Miao BY, Lee SW, Ho PC. Pilot study on the use of repeated doses of sublingual misoprostol in termination of pregnancy up to 12 weeks gestation: efficacy and acceptability. Hum Reprod 2002; 17:654-658. The first use of the sublingual or buccal route of administration of misoprostol is presented in this paper.
75. Chong YS, Chua S, Arulkumaran S. Sublingual misoprostol for first trimester termination of pregnancy: safety concerns. Hum Reprod 2002; 17:2777-2778.
76. Chong YS, Chua S, Shen L, Arulkumaran S. Does the route of administration of misoprostol make a difference? The uterotonic effect and side effects of misoprostol given by different routes after vaginal delivery. Eur J Obstet Gynecol Reprod Biol (in press). The authors show, in a prospective study, that different routes of administering misoprostol greatly affect its uterotonic action and side effects.
77. Gulmezoglu AM, Villar J, Ngoc NT, et al. WHO multicentre randomised trial of misoprostol in the management of the third stage of labour. Lancet 2001; 358:689-695.
78. Abdel-Aleem H, Villar J, Gulmezoglu AM, et al. The pharmacokinetics of the prostaglandin E1 analogue misoprostol in plasma and colostrums after postpartum oral administration. Eur J Obstet Gynecol Reprod Biol 2003; 108:25-28. This paper improves the understanding of the pharmacokinetics of misoprostol in the postpartum woman and has important clinical implications.
79. Chong YS, Chua S, Arulkumaran S. Severe hyperthermia following oral misoprostol in the immediate postpartum period. Obstet Gynecol 1997; 90:703-704.
80. Chong YS, Chua S, El-Refaey H, et al. Postpartum intrauterine pressure studies of the uterotonic effect of oral misoprostol and intramuscular syntometrine. BJOG 2001; 108:41-47.